Variant report
Variant | nsv822085 |
---|---|
Chromosome Location | chr3:50442950-50444565 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:50443137..50446145-chr3:50446726..50449794,4 | K562 | blood: | |
2 | chr3:50440268..50442998-chr3:50446671..50448508,2 | K562 | blood: | |
3 | chr3:50439870..50442603-chr3:50444449..50445977,2 | K562 | blood: | |
4 | chr3:50443241..50445016-chr3:50452041..50453716,2 | K562 | blood: | |
5 | chr3:50395965..50398568-chr3:50443812..50445898,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000126062 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563307205 | chr3:50442980-50442981 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530916204 | chr3:50443018-50443019 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs140950785 | chr3:50443020-50443021 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs548961822 | chr3:50443067-50443068 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139905303 | chr3:50443139-50443140 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs372220675 | chr3:50443143-50443144 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs542276027 | chr3:50443162-50443163 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs193292090 | chr3:50443173-50443174 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs546774787 | chr3:50443185-50443186 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs568265826 | chr3:50443213-50443214 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs529176060 | chr3:50443230-50443231 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs550910859 | chr3:50443231-50443232 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs569091507 | chr3:50443232-50443233 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74994278 | chr3:50443329-50443330 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs74448976 | chr3:50443341-50443342 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs538849573 | chr3:50443426-50443427 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577295413 | chr3:50443429-50443430 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs553121186 | chr3:50443437-50443438 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs146819982 | chr3:50443594-50443595 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs77753325 | chr3:50443601-50443602 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370011001 | chr3:50443605-50443606 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575196525 | chr3:50443610-50443611 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs557207497 | chr3:50443647-50443648 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140317678 | chr3:50443686-50443687 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs145451400 | chr3:50443695-50443696 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs183922961 | chr3:50443768-50443769 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs542611338 | chr3:50443769-50443770 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs573240434 | chr3:50443806-50443807 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540753144 | chr3:50443813-50443814 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs561380720 | chr3:50443880-50443881 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs561831409 | chr3:50443885-50443886 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs34906519 | chr3:50443888-50443889 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs138073690 | chr3:50443914-50443915 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs149107829 | chr3:50443932-50443933 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs143200613 | chr3:50443942-50443943 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs533119034 | chr3:50443954-50443955 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs541700084 | chr3:50443977-50443978 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs35109166 | chr3:50443994-50443995 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs28593422 | chr3:50443996-50443997 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs148186481 | chr3:50444017-50444018 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs71982498 | chr3:50444045-50444046 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs374497200 | chr3:50444046-50444047 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs201073898 | chr3:50444047-50444048 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs35023524 | chr3:50444052-50444053 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs397693761 | chr3:50444053-50444054 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs34531536 | chr3:50444054-50444055 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs34700872 | chr3:50444093-50444094 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs533606693 | chr3:50444100-50444101 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs34452326 | chr3:50444164-50444165 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs187698705 | chr3:50444207-50444208 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Biliary cancer | 19435499 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 22032731 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Gastric cancer | 16891809 | CNVD |
Night blindness | 17160897 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 20409316 | CNVD |
Lung cancer | 17297452 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Developmental delay | 21147756 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:50442200-50444200 | Weak transcription | Skeletal Muscle Male | skeletal muscle |
2 | chr3:50442200-50450800 | Enhancers | Brain Germinal Matrix | brain |
3 | chr3:50442400-50443400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
4 | chr3:50443200-50443400 | Enhancers | Gastric | stomach |
5 | chr3:50443200-50445600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
6 | chr3:50443400-50444000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr3:50443600-50460400 | Weak transcription | Gastric | stomach |
8 | chr3:50444200-50445600 | Enhancers | Spleen | Spleen |